Skip to content
Home›Awards›Amgen USA INC
$

Federal Contract Award

Amgen USA INC

Department of Health and Human Services · January 12, 2024 · FY2024

75A50118F33003Set-aside not reportedNAICS 325414

Obligated

$657,406

Contract details

Award ID
CONT_AWD_75A50118F33003_7505_HHSO100201300006I_7505
PIID
75A50118F33003
Period of performance
September 19, 2018 → March 16, 2024
Place of performance
NEWBURY PARK, CA, USA
Set-aside
Not reported
Pricing type
FIRM FIXED PRICE
PSC
AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
NAICS
325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

Scope

RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION

Parent vehicle (IDV)

Amgen USA INC

UEI Y6NEW42XK544

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Amgen USA INC →
UEI
XPGNQMXHP493
CAGE
5YNZ4
Parent
Amgen USA INC
Address
THOUSAND OAKS, CA

Awarding agency

Department of Health and Human Services →
Sub-agency
Office of Assistant Secretary for Preparedness and Response
Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Funding agency
Department of Health and Human Services
Funding office
BARDA - ASPR / DAAPPO / BARDA DCMA

See every contract Amgen USA INC has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Amgen USA INC profile →